GLP-2 T 15mg

$149.99

According to research Tirzepatide, a novel once-weekly dual GIP and GLP-1 receptor agonist, reduces feelings of hunger, lowers insulin levels, and increases insulin sensitivity, which can cause significant weight loss, improve glucose tolerance, decrease fat/adipose tissue, reduce cardiovascular risk, may provide neuroprotective effects and may be a new tool in treating addiction.

85 in stock

 Compare